Fox Business - The Power to Prosper
Search Site

Beckman Coulter

Synthes confirms in deal talks with J&J

By Katie ReidZURICH (Reuters) - Synthes <SYST.VX> said on Monday it was in takeover talks with Johnson & Johnson <JNJ.N>, after reports the U.S. group is looking to buy the Swiss medical device maker for about $20 billion.A source familiar with the situation told Reuters at the weekend the two sides were in preliminary talks.A deal at $20 billion would mark an 11 percent premium over Synthes's current market capitalization of about $18 billion and would allow healthcare conglomerate J&J to further diversify its healthcare business.Shares in Synthes were indicated 4.5 percent higher, according to pre-market data provided by bank Clariden Leu, after gaining 6.2 percent on Friday as talk circulated that J&J or Medtronic <MDT.N> could be looking to buy the company."In response to market speculation, Synthes Inc confirms that it is engaged in discussions with Johnson & Johnson about a potential business combination transaction," Synthes said in a statement."No assurance can be given as to w...

Read More

  1. LIVE: Earnings' Kick Off


  2. Fixing Your 401(k)

    April 07, 2009 9:04 AM Fixing Your 401(k)by Elizabeth MacDonaldSelect rating Poor Okay Good Great Awesome No votes yetComments »The stock market meltdown has unearth...

  1. Bulls Feast on Deals, Drive Dow to Sixth Day of Green

    FOX Business: The Power to ProsperInspired by a flurry of M&A deals that underscore growing confidence in the recovery, Wall Street climbed to fresh two and-half-yea...

  2. Markets Open Session in Positive Territory

    FBN's Robert Gray breaks down the stories boosting the market early in the trading day.

  3. Marvel Teams up With NBA

    FBN’s Dagen McDowell discusses the league's decision to team up with the entertainment company.

  4. KKR Said To Drop Out Of Beckman Coulter Bid Group -Bloomberg

    KKR & Co. (KKR) has dropped out of a bidding group for lab-equipment maker Beckman Coulter Inc. (BEC), Bloomberg News reported Friday, citing three people with knowl...

  5. Beckman Coulter Shares Hit Year Low on Resignation of CEO

    Beckman Coulter (NYSE:BEC) hit a 52-week low Tuesday after the developer of products used to automate complex biomedical tests said its CEO Scott Garrett has resigne...

  6. Beckman Coulter CEO Abruptly Resigns

    FBN's Robert Gray on the resignation of the medical-test maker's CEO.

  7. Fixing Your 401(k) « Emac's Stock Watch

    April 7, 2009 09:04 AM UTC by Elizabeth MacDonaldFixing Your 401(k)The stock market meltdown has unearthed lots of market fantasies--and deceptions.One of the bigges...

Freebase CC-BY
Source: Beckman Coulter on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL